Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

INTRODUCTION: This study helps to define the implications of breast cancer anti-estrogen resistance 3 (BCAR3) in breast cancer and extends the current understanding of its molecular mechanism of action. BCAR3 has been shown to promote cell proliferation, migration and attachment to extracellular mat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res
Hlavní autoři: Guo, Jimin, Canaff, Lucie, Rajadurai, Charles Vincent, Fils-Aimé, Nadège, Tian, Jun, Dai, Meiou, Korah, Juliana, Villatoro, Manuel, Park, Morag, Ali, Suhad, Lebrun, Jean-Jacques
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311507/
https://ncbi.nlm.nih.gov/pubmed/25499443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0476-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky